One of the top priorities for successfully mitigating COVID-19 is the development of an effective yet safe vaccine. Currently there are more than 100 potential vaccines in development, with projections for commercial availability a year or more away. To provide the latest information, myMatrixx is making regular updates to the “COVID-19 — Searching for Safe and Effective Vaccines” issues document.
The most recent update includes Pfizer and BioNTech’s study results from a Phase III trial evaluating BNT-162. Download the updated document below for more information regarding this and other therapies in development for COVID-19.